Eder, AF, Manno, C.S. Alloimmune hemolytic disease of the fetus and newborn. In Wintrobe’s Clinical Hematology, 11th ed. (Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader BE, (eds). Philadelphia, PA: Lippincott, Williams & Wilkins, 2004.Search in Google Scholar
Moise KJ. Red blood cell alloimmunization in pregnancy. Semin Hematol 2005; 42:169-78.10.1053/j.seminhematol.2005.04.007Search in Google Scholar
Chavez GF, Mulinare J, Edmonds LD. Epidemiology of Rh hemolytic disease of the newborn in the United States. J Am Med Assoc 1991;265:3270–4.10.1001/jama.1991.03460240066029Search in Google Scholar
Joseph KS, Kramer MS. The decline in Rh hemolytic disease: should Rh prophylaxis get all the credit? Am J Public Health 1998;88:209–15.10.2105/AJPH.88.2.209Search in Google Scholar
Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2002. Natl Vital Stat Rep 52:1-116, 2002.Search in Google Scholar
Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004.10.1016/B978-012586585-2/50007-XSearch in Google Scholar
Moise KJ. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000;92:75–81.10.1016/S0301-2115(00)00428-0Search in Google Scholar
Heddle NM, Klama L, Frassetto R, et al. A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy. Transfusion 1993;23:217–20.10.1046/j.1537-2995.1993.33393174447.xSearch in Google Scholar
Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997;89:272-5.10.1016/S0029-7844(96)00434-6Search in Google Scholar
Van der Schoot CE, Tax GH, Rijnders RJ, de Haas M, Christiaens GC. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 2003;17:31-44.10.1053/tmrv.2003.5000112522770Search in Google Scholar
van Kamp IL, Klumper FJ, Oepkes D, et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gyecol 2005; 192:171-7.10.1016/j.ajog.2004.06.06315672021Search in Google Scholar
Prevention of RhD alloimmunization. ACOG Practice Bulletin Number 4. Washington, DC: American College of Obstetricians and Gynecologists, May 1999.Search in Google Scholar
Judd WJ. Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion 2001;41:1445–52.10.1046/j.1537-2995.2001.41111445.x11724993Search in Google Scholar
Garratty G, Do we need to be more concerned about weak D antigens? Transfusion 2005;45: 97-101.10.1111/j.1537-2995.2005.00625.xSearch in Google Scholar
Denomme GA, Wagner FF, Fernandes BJ, Li W, Flegel WA, Partial D, weak D types and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion 2005; 45:1554-60.10.1111/j.1537-2995.2005.00586.xSearch in Google Scholar
Cannon M, Pierce R, Taber EB, Schucker J. Fatal hydrops fetalis caused by anti-D in a mother with partial D. Obstet Gynecol 2003;102:1143-5. Comments: Obstet Gynecol 2004;104:193-5.Search in Google Scholar
Domen RE. Polices and procedures related to weak D phenotype testing and Rh immune globulin administration. Arch Pathol Lab Med 2000;124:1118-21.10.5858/2000-124-1118-PAPRTWSearch in Google Scholar
AABB Standards for Blood Banks and Transfusion Services, 23rd ed. Bethesda, MD: AABB, 2004.Search in Google Scholar
de Silva M, Engelfriet CP, Reesink HW, Current status of immunoprophylaxis with anti-D immunoglobulin. Vox Sang 2003;85:328-37.Search in Google Scholar
Ness PM, Baldwin ML, Niebyl JR. Clinical high-risk designation does not predict excess fetal-maternal hemorrhage. Am J Obstet Gynecol 1987;156: 154-8.10.1016/0002-9378(87)90228-6Search in Google Scholar
Pourbabak S, Rund CR, Crookston KP. Three cases of massive fetomaternal hemorrhage presenting without clinical suspicion. Arch Pathol Lab Med 2004;128:463-5.10.5858/2004-128-463-TCOMFH15043456Search in Google Scholar
Means ND, Bandarenko N, Moise JR KJ, Brecher ME. Likelihood of D heterozygosity in Mestizo Mexicans and Mexican Americans. Immunohematol 2001; 17:22-3.10.21307/immunohematology-2019-537Search in Google Scholar
Singleton BK, Green CA, Avent ND, Martin PG, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95: 12-18.10.1182/blood.V95.1.12Search in Google Scholar
Kim JY, Kim SY, Kim CA, Yon GS, Park SS. Molecular characterization of D- Korean persons: development of a diagnostic strategy. Transfusion 2005;45:345-52.10.1111/j.1537-2995.2005.04311.x15752151Search in Google Scholar
Heckerling PS, Verp MS. Amniocentesis or chorionic villus sampling for prenatal genetic testing: A decision analysis. J Clin Epidemiol 1991; 44:457-70.Search in Google Scholar
Bianchi DW, Avent ND, Costa JM, Van der Schoot CE. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for prime(r) time. Obstet Gynecol 2005; 106:682-3.10.1097/01.AOG.0000179477.59385.9316199645Search in Google Scholar
Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci 1996;93:705-8.10.1073/pnas.93.2.705401178570620Search in Google Scholar
Oepkes D, Seaward PG, Vandenbussche F, Windrim R, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006;355:156-64.10.1056/NEJMoa05285516837679Search in Google Scholar
Vaughan JI, Manning M, Warwick RM, et al. Inhibition of erythroid progenitor cells by anti-K antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798-803.10.1056/NEJM1998031933812049504940Search in Google Scholar
Denomme GA, Ryan G, Seaward PGR, Kelly EN, Fernandes BJ. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17. Transfusion 2004;44:1357-60.10.1111/j.1537-2995.2004.04082.x15318861Search in Google Scholar
Herschel M, Karrison T, Wen M, et al. Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antigen test-negative neonates. Pediatrics 2002;110: 127-30.10.1542/peds.110.1.12712093957Search in Google Scholar
Dinesh D. Review of positive direct antiglobulin tests found on cord blood sampling. J Pediatr Child Health. 2005;41:504-7.10.1111/j.1440-1754.2005.00692.x16150068Search in Google Scholar
Biondi CS, Cotorruelo CM, Ensinck A, Racca LL, Racca AL. Use of the erythrophagocytosis assay for predicting the clinical consequences of immune blood destruction. Clin Lab 2004;50:265-70.Search in Google Scholar
American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia, Clinical Practice Guideline: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.10.1542/peds.114.1.29715231951Search in Google Scholar
Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Eng J Med 2006;354:1889-900.10.1056/NEJMoa05424416672700Search in Google Scholar
